EUR ARCH OTO-RHINO-L 润色咨询

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

出版年份:1990 年文章数:5248 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:10.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2023-01-09 ms7000001893832347 来自湖北省

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:meta分析;临床
    经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-03-21 今天审稿人爸爸心情好了吗

    审稿速度:1.0
    经验分享:接受很快,给个参考
    2.23:投稿
    3.16:小修
    3.21:接受
    前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-11-30 Yhao 来自陕西省

    请问各位大神第二次外审需要多久?

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-11-11 Yhao

    10.23 Under Review至今,状态没有任何变化。
    请问各位大神,这个杂志的审稿周期一般是一个月吗?

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-11-05 1489a406m08暂无昵称

    偏重的研究方向:肿瘤;头颈部肿瘤;鼻
    经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-10-21 肿瘤-Doctor Zhu

    审稿速度:2.0
    偏重的研究方向:头颈部肿瘤
    经验分享:投稿 2022年09月4日
    2022年9月6日under review
    2022年9月11日 under review
    2022年9月23日under review
    2022年10月18日 accept
    本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享


    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-10-15 肿瘤-Doctor Zhu

    请问大家一般都会under review 多久呢 ,我中间时间变换了几次

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-07-29 ms5000001292778018

    UNDER review·两个月了 还没有消息

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-09-16 ms5000001292778018

    文章accept之后 还需要做什么处理吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:meta分析;临床<br>经验分享:2022年9月中旬在该杂志社投了一篇meta分析,11.1第一次小修,12.14左右第二次小修(非常小而且非常细致,审稿人直接建议我去掉哪个词,这种感觉),12.20就接收了,而且很友好地让选择是OA(2.5wRMB左右)还是传统订阅,虽然医院没有报销版面费的上限,但还是选择了非OA。由于感觉这个杂志蛮友好的,所以11.24提交了另外一篇meta,不过两篇文章的投稿者即通讯作者不一样;2023年1.6就直接发邮件说他们已经接收了???貌似只有一个审稿人简单夸了一下,就表示要接收了。整体而言我感觉比较容易?希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1204729, encodeId=21031204e293b, content=审稿速度:1.0<br>经验分享:接受很快,给个参考<br>2.23:投稿<br>3.16:小修<br>3.21:接受<br>前后不到一个月,都是当天投稿,第二天编辑就处理送审了,高效杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Mon Mar 21 20:49:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103602, encodeId=e7322103602a1, content=请问各位大神第二次外审需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Wed Nov 30 22:13:12 CST 2022, time=2022-11-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099989, encodeId=4b0b2099989bb, content=10.23 Under Review至今,状态没有任何变化。<br>请问各位大神,这个杂志的审稿周期一般是一个月吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Nov 11 22:27:14 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098633, encodeId=e187209863376, content=偏重的研究方向:肿瘤;头颈部肿瘤;鼻<br>经验分享:2022-8-26左右 投稿 2022-8-27 with editor 2022-8-28左右under review 2022-9-28小修(两个小问题:1.因为投稿时图片选择tiff格式,投稿系统生成PDF文件内图片变模糊,两个审稿人均要求提高图片分辨率,返修后改成图片改成EPS格式,投稿系统生成的PDF内图片才清晰。2.其中一个审稿人指出文章中一处语法缺陷) 2022-9-30返修回去 2022-10-1 with editor 2022-10-8左右再次under review 2022-10-15左右二审结束,等编辑定夺 2022-10-25接收 2022-11-4出版社Springer Nature发邮件到通讯邮箱(内含一个12小时内有效的链接),让选择出版方式(是否付版面费) 目前等proof中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=1489a406m08暂无昵称, createdTime=Sat Nov 05 01:11:21 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095176, encodeId=26ec20951e65a, content=审稿速度:2.0<br>偏重的研究方向:头颈部肿瘤<br>经验分享:投稿 2022年09月4日<br>2022年9月6日under review<br>2022年9月11日 under review<br>2022年9月23日under review<br>2022年10月18日 accept<br>本人头颈部肿瘤相关专业,现在研究生第二年,这也算的上是我的处女作,从文章的选题、设计、数据分析以及论文撰写基本都是我自己一个人在做,前期工作做了很久,所以当我看到reviewer的意见 This is an interesting study, The study is well conducted and, in my opinion, deserves to be published in EAOR,心里感受既惊喜又害怕。总的来说,这本杂志我是很推荐的,最后祝大家也能顺利accept啊。后面应该就是proof 和 online ,我准备选择非OA,后续情况我会继续和大家一起分享<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Oct 21 14:38:47 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢 ,我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235490, encodeId=8d551235490d4, content=UNDER review·两个月了 还没有消息 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Jul 29 16:10:38 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249326, encodeId=5b4f1249326ad, content=文章accept之后 还需要做什么处理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Fri Sep 16 12:48:31 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180842, encodeId=3fdf118084251, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/a3fba465d31b4b81a3479418b484098b/9eb3edbe0ae64ec78ae5801509ad9f32.jpg, createdBy=b1e75329779, createdName=kirianna, createdTime=Wed Jan 05 13:20:12 CST 2022, time=2022-01-05, status=1, ipAttribution=)]
    2022-01-05 kirianna

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:我郁闷si了,这个杂志,9月初投稿,10月下旬只找了1个审稿人,小修,然后到了来年的1月1日,审稿人3的意见是不需要修改,我估计编辑都没看,直接发回来让我修改,我都蒙了,然后我给编辑发邮件说不需要修改,我们回复了升高人的意见(就是跟审稿人说了谢谢),结果,第二天再看状态,又拿出去under review了!!!!前前后后至少4个月!这个杂志我真是醉了!这审稿人怎么就一个一个的找啊?现在又送审是因为审稿人2还没找到么?半年都过去了!!

    6

    展开6条回复
共174条页码: 3/18页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分